Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simple Blinded Multicenter Randomized Comparative Study to Assess Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE

NCT06834100 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.

NCT NCT06834100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simple Blinded Multicenter Randomized Comparative Study to Assess Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE
Lead sponsor
NPO Petrovax
Phase
Phase 3
Overall status
Recruiting
Start date
February 12, 2025
Completion date
December 31, 2025
Enrollment
240 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

infections, meningococcal